Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to implement an opt-out protocol to guide appropriate de-escalation of antibiotics in qualifying patients. The protocol, determined over the course a year with the help of a large, well-rounded expert panel, will be used by pharmacists to recommend de-escalation of antibiotics to hospital providers. Providers can then decide whether or not to follow the recommendation in determining the best treatment pathway for his or her patient.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03517007
Study type Interventional
Source Duke University
Contact
Status Completed
Phase N/A
Start date September 12, 2018
Completion date August 10, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT04681339 - Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
Enrolling by invitation NCT06106204 - Reducing Overuse of Antibiotics at Discharge Home N/A
Recruiting NCT04754737 - Antibiotic Usage Prior to OnabotulinumtoxinA Injection N/A
Not yet recruiting NCT06278896 - Early Neutropenic Fever De-escalation of Antibiotics Study Phase 3
Completed NCT03245879 - Antibiotic Stewardship in Small Hospitals N/A
Not yet recruiting NCT04453540 - FilmArray and Management of ICU Patients With Pneumonia in the Covid-19 Context
Enrolling by invitation NCT06187662 - BrighT STAR LIBRA: Leveraging Implementation Science for Blood Culture Reduction Approaches N/A
Recruiting NCT06197269 - Efficacy And Safety Of Short Course Antibiotic Therapy In Preterm Neonates With Early Onset Sepsis N/A